Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-04

FDA Approved: DAPSONE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved Aurobindo Pharma Limited's Original Abbreviated New Drug Application for DAPSONE (dapsone), a generic antibiotic used for dermatitis herpetifor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DAPSONE (dapsone)

Snippet

ORIG AP for DAPSONE (DAPSONE)